UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 197

Sortiert nach

Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

Journal of internal medicine, 2015-08, Vol.278 (2), p.185-192

2015

Volltextzugriff (PDF)

Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease

Seminars in arthritis and rheumatism, 2020-10, Vol.50 (5), p.846-853

2020

Volltextzugriff (PDF)

A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome

Lupus, 2015-03, Vol.24 (3), p.315-320

2015

Volltextzugriff (PDF)

One year in review 2017: systemic vasculitis

Clinical and experimental rheumatology, 2017-03, Vol.35 Suppl 103 (1), p.5

2017

Volltextzugriff (PDF)

Preliminary classification criteria for the cryoglobulinaemic vasculitis

Annals of the Rheumatic Diseases, 2011-07, Vol.70 (7), p.1183-1190

2011

Volltextzugriff (PDF)

Role of oral cyclophosphamide in the treatment of giant cell arteritis

Rheumatology (Oxford, England), 2012-09, Vol.51 (9), p.1677-1686

2012

Volltextzugriff (PDF)

Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring

Clinical rheumatology, 2015-01, Vol.34 (1), p.171-174

2015

Volltextzugriff (PDF)

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

Reumatismo, 2022-02, Vol.73 (4)

2022

Volltextzugriff (PDF)

Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab

Clinical and experimental rheumatology, 2012-11, Vol.30 (6), p.922

2012

Volltextzugriff (PDF)

AB0586 Persistent Rather Than Fluctuating Serum Cryoglobulins are Associated with Cryoglobulinemic Vasculitis in Primary SjÖgren's Syndrome, and Related to the Risk of Lymphoma

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1096-1096

2015

Volltextzugriff (PDF)

AB0167 ACR/EULAR Remission in Early Rheumatoid Arthritis Associates with A Shorter Time To Fulfilment The Classification Criteria and A Lower Bmi

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.953-953

2016

Volltextzugriff (PDF)

Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients

Transfusion and apheresis science, 2018-10, Vol.57 (5), p.639-645

2018

Volltextzugriff (PDF)

FRI0324 Work Productivity in Primary Sjögren's Syndrome: A Cross-Sectional Multicenter Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.552-552

2016

Volltextzugriff (PDF)

THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.294-295

2016

Volltextzugriff (PDF)

B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection

Rheumatology (Oxford, England), 2007-01, Vol.46 (1), p.37-43

2007

Volltextzugriff (PDF)

Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids

Rheumatology (Oxford, England), 2006-07, Vol.45 (7), p.842-846

2006

Volltextzugriff (PDF)

Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy Hepatitis C Virus related: always correct therapeutic approach?

Acta gastro-enterologica belgica, 2020-10, Vol.83 (4), p.672

2020

Volltextzugriff (PDF)

Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study

Scandinavian journal of rheumatology, 2015-01, Vol.44 (1), p.36-41

2015

Volltextzugriff (PDF)

The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis

The pharmacogenomics journal, 2016-06, Vol.16 (3), p.238-242

2016

Volltextzugriff (PDF)

THU0402 Increased Expression of Baff Receptor on B Cells May be Implicated in Delayed Response in Systemic Lupus Erythematosus Patients Under Belimumab Therapy

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.342-342

2015

Volltextzugriff (PDF)

THU0394 Worsening of Systemic Activity and Increases of B-Cell Biomarkers in sjögren's Syndrome after Suspension of Belimumab Treatment: Long-Term Follow-Up After the End of the Beliss Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.339-339

2015

Volltextzugriff (PDF)

THU0299 B Cell Compartment and Pharmacodynamics of Belimumab in Systemic Lupus Erythematosus: Early Clinical Efficacy by Depletion of CD27- and Increase of CD27+ B Cells

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.295-295

2016

Volltextzugriff (PDF)

Efficacy of abatacept in a refractory case of adult-onset Still's disease

Clinical and experimental rheumatology, 2010-03, Vol.28 (2), p.265

2010

Volltextzugriff (PDF)

SAT0290 A Higher Disease Activity in Anti-Ssa/ssb Positive Sjögren's Syndrome Is Explained by A Higher Clinical and Biological B-Cell Activation

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.773

2016

Volltextzugriff (PDF)

THU0341 Correlation between Essdai and Clinessdai in A Real-Life Cohort of Sjögren's Syndrome Patients

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.310

2016

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(102)
Humans
(92)
Rheumatology
(75)
Female
(63)
Male
(53)
Middle Aged
(50)
Aged
(38)
Adult
(35)
Medicin Och Hälsovetenskap
(22)
Treatment Outcome
(20)
Biological And Medical Sciences
(14)
Lymphoma
(14)
Medical Sciences
(14)
Retrospective Studies
(14)
Severity Of Illness Index
(14)
Patients
(13)
Rituximab
(13)
Cryoglobulinaemia
(12)
Diseases Of The Osteoarticular System
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease

A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome

One year in review 2017: systemic vasculitis

Preliminary classification criteria for the cryoglobulinaemic vasculitis

Role of oral cyclophosphamide in the treatment of giant cell arteritis

Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab

AB0586 Persistent Rather Than Fluctuating Serum Cryoglobulins are Associated with Cryoglobulinemic Vasculitis in Primary SjÖgren's Syndrome, and Related to the Risk of Lymphoma

AB0167 ACR/EULAR Remission in Early Rheumatoid Arthritis Associates with A Shorter Time To Fulfilment The Classification Criteria and A Lower Bmi

Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients

FRI0324 Work Productivity in Primary Sjögren's Syndrome: A Cross-Sectional Multicenter Study

THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial

B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection

Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids

Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy Hepatitis C Virus related: always correct therapeutic approach?

Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study

The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis

THU0402 Increased Expression of Baff Receptor on B Cells May be Implicated in Delayed Response in Systemic Lupus Erythematosus Patients Under Belimumab Therapy

THU0394 Worsening of Systemic Activity and Increases of B-Cell Biomarkers in sjögren's Syndrome after Suspension of Belimumab Treatment: Long-Term Follow-Up After the End of the Beliss Study

THU0299 B Cell Compartment and Pharmacodynamics of Belimumab in Systemic Lupus Erythematosus: Early Clinical Efficacy by Depletion of CD27- and Increase of CD27+ B Cells

Efficacy of abatacept in a refractory case of adult-onset Still's disease

SAT0290 A Higher Disease Activity in Anti-Ssa/ssb Positive Sjögren's Syndrome Is Explained by A Higher Clinical and Biological B-Cell Activation

THU0341 Correlation between Essdai and Clinessdai in A Real-Life Cohort of Sjögren's Syndrome Patients

Suchergebnisse filtern